PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.24

Change

+0.11 (+1.35)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-1.02 (-3.17%)

USD 11.53B
QLD ProShares Ultra QQQ

-0.89 (-0.94%)

USD 5.39B
FNGU MicroSectors FANG+ Index 3X Le..

-5.69 (-1.47%)

USD 5.13B
SSO ProShares Ultra S&P500

-0.57 (-0.66%)

USD 4.50B
UPRO ProShares UltraPro S&P500

-0.78 (-0.96%)

USD 3.53B
TECL Direxion Daily Technology Bull..

-2.35 (-2.92%)

USD 3.15B
LABU Direxion Daily S&P Biotech Bul..

-0.51 (-0.37%)

USD 0.94B
USD ProShares Ultra Semiconductors

-2.95 (-2.72%)

USD 0.86B
DPST Direxion Daily Regional Banks ..

+1.54 (+1.52%)

USD 0.77B
YINN Direxion Daily FTSE China Bull..

-0.32 (-1.45%)

USD 0.76B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.32% 30% F 48% F
Dividend Return 0.63% 46% F 14% F
Total Return 6.96% 29% F 41% F
Trailing 12 Months  
Capital Gain 1.10% 20% F 24% F
Dividend Return 1.07% 35% F 14% F
Total Return 2.18% 18% F 21% F
Trailing 5 Years  
Capital Gain -43.65% 26% F 12% F
Dividend Return 1.60% 26% F 4% F
Total Return -42.05% 25% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain -2.84% 12% F 24% F
Dividend Return -2.37% 10% F 15% F
Total Return 0.47% 37% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 105.70% 36% F 7% C-
Risk Adjusted Return -2.24% 10% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.